Technical Analysis for ANIK - Anika Therapeutics Inc.

Grade Last Price % Change Price Change
grade B 53.91 -1.73% -0.95
ANIK closed down 1.73 percent on Friday, September 13, 2019, on 66 percent of normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical ANIK trend table...

Date Alert Name Type % Chg
BB Squeeze Ended Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup -1.73%
Bollinger Band Squeeze Range Contraction -1.73%
NR7 Range Contraction -1.73%
Bollinger Band Squeeze Range Contraction -2.99%
New Downtrend Bearish -3.06%
Bullish Engulfing Bullish -3.06%

Older signals for ANIK ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Anika Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid (HA), a naturally occurring biocompatible polymer found in the body. The company's products include ORTHOVISC, ORTHOVISC mini, and MONOVISC for the treatment of osteoarthritis of the knee and various other joints; Hyalofast, a biodegradable support for human bone marrow mesenchymal stem cells that is used in connection with soft tissue regeneration; Hyalonect, a woven gauze used as a graft wrap; Hyaloss, HYAFF fibers used to mix blood/bone grafts to form a paste for bone regeneration; and Hyaloglide, an ACP gel used in tenolysis treatment. It also provides wound care products that comprise Hyalomatrix and Hyalofill, for treatment of complex wounds, such as burns and ulcers; and Hyalograft 3D and Laserskin scaffolds for use in connection with the regeneration of skin, as well as ELEVESS, an aesthetic dermatology product for facial wrinkles and scar remediation. In addition, the company offers AMVISC, AMVISC Plus, STAARVISC-II, Optivisc, AnikaVisc, and AnikaVisc Plus that are injectable HA products used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation. Further, it provides Hyalobarrier, a post-operative adhesion barrier; INCERT, a HA product for the prevention of spinal post-surgical adhesions; and Merogel, a woven fleece nasal packing, as well as Merogel Injectable, a viscous hydrogel. Additionally, the company offers HYVISC, an injectable HA product used for the treatment of joint dysfunction in horses. Anika Therapeutics, Inc. markets its products directly, as well as through a network of distributors in the United States, Europe, and internationally. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
Medicine Stem Cells Osteoarthritis Therapeutic Products Cataract Burns Scar Therapeutic Treatment Of Osteoarthritis Bone Grafting Glycosaminoglycans Hyaluronic Acid Oral And Maxillofacial Surgery Wound Care Products
Is ANIK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 58.93
52 Week Low 29.01
Average Volume 202,304
200-Day Moving Average 39.1066
50-Day Moving Average 51.4498
20-Day Moving Average 56.065
10-Day Moving Average 55.418
Average True Range 1.9711
ADX 33.69
+DI 12.859
-DI 22.8695
Chandelier Exit (Long, 3 ATRs ) 53.0167
Chandelier Exit (Short, 3 ATRs ) 58.4133
Upper Bollinger Band 57.9185
Lower Bollinger Band 54.2115
Percent B (%b) -0.08
BandWidth 6.611968
MACD Line 0.6604
MACD Signal Line 1.2841
MACD Histogram -0.6237
Fundamentals Value
Market Cap 790.22 Million
Num Shares 14.7 Million
EPS 2.25
Price-to-Earnings (P/E) Ratio 23.96
Price-to-Sales 7.22
Price-to-Book 3.29
PEG Ratio 2.68
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 58.08
Resistance 3 (R3) 58.09 56.71 57.39
Resistance 2 (R2) 56.71 55.65 56.71 57.15
Resistance 1 (R1) 55.31 54.99 54.62 55.30 56.92
Pivot Point 53.93 53.93 53.59 53.93 53.93
Support 1 (S1) 52.53 52.87 51.84 52.52 50.90
Support 2 (S2) 51.15 52.21 51.15 50.67
Support 3 (S3) 49.75 51.15 50.44
Support 4 (S4) 49.74